In this study, we provide evidence supporting the notion that suppression of WNT/β-catenin signaling-dependent transcriptional activation of survivin is a vital mechanism underlying the proapoptotic effect of Obatoclax on human CRC cells. Here, BIRC5 is linked to colorectal carcinoma.